Exosomal Circsafb2 Reshaping Tumor Environment to Promote Renal Cell Carcinoma Progression by Mediating M2 Macrophage

Xin Huang1, Jingyu Wang1, Jibin Guan2

  • 1Department of Nephrology, The First Hospital of China Medical University, Shenyang, China.

Abstract

Insights

Circular RNA SAFB2 (circSAFB2) in exosomes promotes renal cell carcinoma (RCC) immune escape by polarizing M2 macrophages. This finding reveals a new mechanism for exosomal circRNA in RCC progression and offers a potential target for therapy.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Macrophages are key stromal cells in tumors, with M2 subtypes promoting immunosuppression and tumor growth.
  • Exosomes mediate intercellular communication, and circular RNAs (circRNAs) regulate cancer progression.
  • The role of exosomal circRNAs in macrophage polarization in renal cell carcinoma (RCC) remains unclear.

Purpose of the Study:

  • To investigate the function of exosomal circRNAs in regulating macrophage polarization in RCC.
  • To identify specific circRNAs involved in RCC-derived exosome-mediated immune responses.
  • To elucidate the molecular mechanisms underlying exosomal circRNA's role in RCC progression and immune evasion.

Main Methods:

  • Characterization of RCC-derived exosomes and assessment of their effects on RCC cells.
  • Bioinformatic analysis of serum-derived exosomal circRNAs from RCC patients.
  • Validation of circSAFB2 expression, localization, and its role in M2 macrophage polarization via molecular assays and in vivo mouse models.

Main Results:

  • circSAFB2 was found to be highly expressed in RCC tissues and RCC-derived exosomes.
  • Exosomal circSAFB2 was shown to mediate M2 macrophage polarization.
  • This polarization was linked to the miR-620/JAK1/STAT3 signaling axis, promoting RCC metastasis.

Conclusions:

  • circSAFB2 facilitates immune escape in RCC by orchestrating M2 macrophage polarization through the miR-620/JAK1/STAT3 pathway.
  • This study identifies a novel mechanism of exosomal circSAFB2 in driving RCC progression.
  • circSAFB2 presents a potential therapeutic target for overcoming exosome-mediated tumor immune evasion in RCC.